Daglig oral behandling med 2, 5 mg ibandronsyre - tabletter resulterede i en tiltagende øgning af BMD både vertebralt og non- vertebralt.
Daily oral treatment with ibandronic acid 2.5 mg tablets resulted in progressive increases in BMD at vertebral and nonvertebral sites of the skeleton.